Market Research Logo
Region: Middle East
Category: Life Sciences

Middle East Life Sciences

(968 reports matching your criteria)
  • Iran Medical Devices Q1 2019

    ... the forecast period, with imports supplyingmuch of the market. Investments in healthcare by the Iranian government and private sector, and plans to boost medical tourismwill support market growth. Moreover, Iran will be pushed to locally ... Read More

  • Israel Medical Devices Q1 2019

    ... a very dynamic market in terms of medical device start-ups.Domestic industry strengths include diagnostic imaging and dental instruments. With increased investment in areas such as dentalproducts, the market will see steady growth from 2019 onwards. Read More

  • Lebanon Medical Devices Q1 2019

    ... increasing incidence of chronic diseases, medical tourism, the predominance ofprivate healthcare providers, import reliance, stronger market regulation and new global partnerships. However, ongoing politicalinstability and limited funds to cover Syrian refugees will contain market growth. Read More

  • Saudi Arabia Medical Devices Q1 2019

    ... medical device market. The efficiency of the healthcare system is improving, andthere is greater support of the private sector in the provision of medical services and products. A key risk to our positive outlook forthe ... Read More

  • Oman Medical Devices Q1 2019

    ... exports, while rising oil prices support greater government spending.Modernisation of hospitals and other key health sector development projects will drive market growth. Imports will continue todominate over the long term as domestic manufacturing capabilities lag. Read More

  • Lebanon Pharmaceuticals & Healthcare Q1 2019

    ... include compulsory covers, will support significant short-term growth in terms of written premiums. In the smaller life segment, the outlook is more subdued, as low average income ratesrestrict capacity for savings and investments to a ... Read More

  • Iraq Pharmaceuticals & Healthcare Q1 2019

    ... treatment will support rising healthcarespending. Although the new government will look to increase spending on public service delivery and social welfare, structuralchallenges and low spending per capita on medicine will limit opportunities presented to drugmakers ... Read More

  • Israel Pharmaceuticals & Healthcare Q1 2019

    ... a thriving biotechnology start-up culture as well asmaking necessary funding, and regulatory adjustments for its five-year national digital health plan will future-proof Israel'stechnological infrastructure and ensure it remains above the majority of its regional peers. Read More

  • Bahrain Pharmaceuticals & Healthcare Q1 2019

    ... patented medicines, most innovative drugmakers willlikely focus on the larger regional markets, such as the UAE and Saudi Arabia. Nonetheless, Bahrain’s rapidly growing population,relatively strong regulatory environment and implementation of a universal health insurance scheme ... Read More

  • Kuwait Medical Devices Q1 2019

    ... currency depreciation. High population growth, the increasing burden of non-communicablediseases, improving foreign policy, healthcare infrastructure developments in accordance with the National Development Plan, theencouragement of PPPs and health insurance expansion will remain key market drivers. Read More

  • Kuwait Pharmaceuticals & Healthcare Q1 2019

    ... well-placed to attract greater investment, themajority of medicines will remain sourced from abroad from multinational drugmakers. At the same time,controversial Kuwaitisation policies have precipitated a shortage of healthcare staff which continues to threaten the sector'sstability. Read More

  • Middle East And North Africa Pharmaceuticals & Healthcare Q4 2018

    ... opportunities for multinational drugmakers looking to expand to emergingmarkets. Heightened industry and country risk dissuade company interest and the larger markets dominate multinational activityfor patented medicine sales. Ample opportunities exist in the generics market segment. Read More

  • United Arab Emirates Pharmaceuticals & Healthcare Q1 2019

    ... expansion of private healthcare coverage and the modernisationof health infrastructure will contribute to drive prescription market growth. Stricter pricing controls, generic drug substitution and anunfavourable demographic profile will act act headwinds to firms over the ... Read More

  • United Arab Emirates Medical Devices Q1 2019

    ... rising healthcare costs, the government will increase private sector participation. Population growth, achanging epidemiology, a growing medical tourism industry, healthcare infrastructure developments, an expanding healthinsurance, digital transformation and new technologies will remain key market drivers. Read More

  • Middle East And North Africa Medical Devices Q4 2018

    ... medical device market growth. Despite its slowdown, Saudi Arabia will continue to lead the GCC market,while Iran will spearhead the non-GCC market. The UAE will remain a predominant base for multinational medical device companiesto set ... Read More

  • Qatar Pharmaceuticals & Healthcare Q4 2018

    ... and infrastructure continues to expand to meet therising demand for healthcare. Meanwhile, we expect pharmaceutical and healthcare spending to benefit from improving businessand consumer sentiment on the back of rising oil prices. That said, the ... Read More

  • Project Insight: Healthcare Construction Projects, Middle East And Africa

    ... World Health Organization index of access to 16 necessary services. An aging population in the Middle East could push up demand across the region’s healthcare industry, but a focus on technology-focused healthcare delivery models, which ... Read More

  • Oman Pharmaceuticals & Healthcare Q4 2018

    ... strong public healthcaresystem and a significant underlying burden of chronic disease. However, manufacturers will face an increasingly cost-consciouspublic sector in light of government budget constraints. Phased pharmaceutical price reductions pose near-term risks formanufacturers and importers. Read More

  • Jordan Pharmaceuticals & Healthcare Q4 2018

    ... non-communicable diseases among the population. Meanwhile, we expect the government tomaintain a positive business environment for the pharmaceutical industry due to its strategic importance to Jordan's economy,ensuring that the country remains a regional manufacturing hub. Read More

  • Iraq Medical Devices Q4 2018

    ... from the reconstruction of damaged health infrastructure but politicalinstability risks and tepid economic growth will weigh on market growth. As there is very little domestic medical device production,the market will remain heavily reliant on imports. Read More

  • Bahrain Medical Devices Q4 2018

    ... on imported medical devices as manufacturing capabilities in thecountry are limited. Population growth, a changing epidemiological profile and increasing health expenditure will be other growthdrivers, despite ongoing political instability and a lack of meaningful reforms. Read More

  • Iran Pharmaceuticals & Healthcare Q4 2018

    ... and has triggered intense negotiations surrounding theIslamic Republic's future ability to integrate into the global economy. Although the supply of medical equipment and devices willsteadily decline, Iran's healthily domestic drug production capabilities and limited exposure ... Read More

  • Saudi Arabia Pharmaceuticals & Healthcare Q4 2018

    ... 2030’ encouraging the expansion of manufacturingagreements in the country. While regulatory risks remain prevalent, and recent disputes with European players highlightchallenges of doing business in the country, positive market drivers will ensure robust long-term opportunities ... Read More

  • Pharmaceuticals and Medical Equipment in Saudi Arabia

    ... for healthcare development and the government’s production localisation incentives. Under the 2017 budget, the government allocated SAR120 billion to health and social development. This represented a 20% increase from a year earlier. However, at the ... Read More

  • GCC Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

    ... of US$ 776 Million by 2023, exhibiting a CAGR of 12.1% over the forecast period. Generic injectables are equivalents of brand-name injectables with respect to quality, dosage, route of administration, performance, strength and intended use. ... Read More

< prev 1 3 4 5 6 7 8 9 10